RANBP9

RAN Binding Protein 9: A scaffold protein involved in signal transduction, cell cycle regulation, and cancer progression.

Gene Information Card

Symbol RANBP9
Full Name RAN Binding Protein 9
Gene Type protein-coding
Chromosomal Location 6p23
NCBI Gene ID 10048 ncbi.nlm.nih.gov/gene/10048
Ensembl ID ENSG00000112659
UniProt ID Q96S59
OMIM ID 603854
HGNC ID 9850
Aliases RANBPM, RanBP7, RanBP9

Description

RANBP9 encodes a scaffold protein that interacts with RAN, a small GTPase involved in nucleocytoplasmic transport. The protein also binds to various signaling molecules, including receptors for TGF-beta, BMP, and androgen, modulating their activity. It plays roles in cell cycle progression, apoptosis, and cytoskeletal organization. RANBP9 is implicated in several cancers, where it can act as either a tumor suppressor or oncogene depending on context.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer RANBP9 overexpression enhances cell proliferation and migration; interacts with androgen receptor to promote growth. PMID: 21947297; COSMIC
Prostate Cancer RANBP9 modulates androgen receptor signaling; altered expression correlates with disease progression. PMID: 21947297; COSMIC
Colorectal Cancer RANBP9 expression is upregulated; promotes invasion and metastasis via EMT pathways. PMID: 25620004; COSMIC
Lung Cancer RANBP9 overexpression associated with poor prognosis; promotes cell cycle progression. PMID: 25620004; COSMIC
Hepatocellular Carcinoma RANBP9 expression is elevated; contributes to cell proliferation and migration. PMID: 25620004; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 15.2 Medium
Brain 10.5 Medium
Lung 8.3 Low
Liver 6.1 Low
Breast 5.4 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 12.0 Embryonic kidney; high expression
HeLa 9.5 Cervical cancer; moderate expression
MCF7 7.8 Breast cancer; moderate expression
A549 6.2 Lung cancer; low expression
HepG2 5.0 Liver cancer; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412Cys) Missense <0.1% Unknown; rare variant in COSMIC
c.567G>A (p.Gly189Arg) Missense <0.1% Unknown; rare variant in COSMIC
c.890_891insA (p.Thr297fs) Frameshift <0.1% Predicted loss of function; rare in COSMIC
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Thr297fs) are predicted to cause loss of function by truncating the protein.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in COSMIC or ClinVar.

Dominant Negative (DN)

No confirmed dominant-negative mutations reported.

Pathways

• TGF-beta signaling pathway (Reactome: R-HSA-170834)
• BMP signaling pathway (Reactome: R-HSA-201451)
• Androgen receptor signaling pathway (Reactome: R-HSA-5625740)
• Cell Cycle
• Mitotic (Reactome: R-HSA-69278)

Protein Summary

RANBP9 is a 729-amino acid scaffold protein containing a SPRY domain and a LisH motif. It localizes to the cytoplasm and nucleus, interacting with RAN, various receptors (e.g., TGFBR1, BMPR1A, AR), and signaling intermediates. It modulates receptor trafficking, signal transduction, and cell cycle progression. The protein is widely expressed, with highest levels in testis and brain. Dysregulation of RANBP9 is linked to multiple cancers, where it can promote or suppress tumorigenesis depending on cellular context.

Related Products

Product name Cat.No. Species Gene ID
RANBP9 Knockout HEK293 Cell Line EDJ-KQ6877 Human 10048 Details Get a Quote
RANBP9 Knockout A-549 Cell Line EDJ-KQ31467 Human 10048 Details Get a Quote
RANBP9 Knockout HCT 116 Cell Line EDJ-KQ31468 Human 10048 Details Get a Quote
RANBP9 Knockout HeLa Cell Line EDJ-KQ31469 Human 10048 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: